Utah AI Healthcare Sandbox Launches New Health Care Pilots — With Governance Question Marks
OVERVIEWUtah's expansion of its AI healthcare sandbox to include new pilots for drug management, women's health applications, and autonomous prescribing has raised questions about governance adequacy, third-party evaluation rigor, and the long-term sustainability of state-level regulatory innovation. Governance Concerns: - Clarity on liability allocation when AI systems cause harm - Adequacy of third-party evaluation frameworks - Patient consent and disclosure requirements - Interstate coordination and divergent state approaches - Transition from sandbox to permanent regulatory status While Utah's approach is pragmatic—allowing controlled experimentation rather than prohibiting AI—observers question whether state-level sandboxes can provide sufficient oversight of systems that may have broad clinical impact. The success of the Utah model depends heavily on the rigor of third-party evaluation and the willingness to revoke authorization if safety signals emerge. The sandbox also raises questions about national regulatory fragmentation: if multiple states adopt different AI authorization frameworks, healthcare organizations operating nationally will face complex compliance requirements. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.